Archive for 2007

Herbert Boyer

It’s important to remember where the biotechnology industry comes from: the demonstration of gene splicing by Herbert Boyer and Stanley Cohen in 1973. Investor’s Business Daily has a great non-interview (Boyer doesn’t give interviews) profile of Boyer, retelling the story of Boyer’s meeting with Robert Swanson and the formation of Genentech, one of the first […]



Functional Overview of the Biotechnology Industry

Here’s a slideshow of the presentation I give to students when I’m asked to give them a general introduction to the business of biotechnology. The material is drawn from my book, Building Biotechnology. Go ahead and post any questions you may have in the comments.



Drug Patent Expirations in June 2007

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in June 2007*Drugs may be covered by more than one patent Tradename Applicant Generic Name Patent Number Patent Expiration AEROBID Roche Palo flunisolide 4,933,168 JUN 12,2007 ANTHELIOS SX Loreal Usa avobenzone; ecamsule; octocrylene 4,585,597 JUN 16,2007 ESTRING Pharmacia And Upjohn estradiol 4,871,543 JUN 12,2007 ESTRING Pharmacia And Upjohn estradiol […]



Carnival of Biotechnology

Welcome to the May 25th 2007 edition of Carnival of Biotechnology. Finance and business development The big news on the web is Google’s investment in 23andMe, described here by the California Biotech Law Blog. International biotech Business Week has an article on The Rush To Test Drugs In China. This is a story with a […]



The global spread of biotechnology

I’ve been tracking the global spread of biotechnology for quite a while now. I’m fascinated with why biotechnology has taken root so strongly in the United States while many other countries are struggling to develop critical mass. This is the topic of a paper I’ve recently co-submitted in response to a request from the American […]



Career Development at UNC Chapel Hill

I’ll be giving a talk on career development in biotechnology at UNC-Chapel Hill on Wednesday May 16th at 4pm in the Bioinformatics Building (ground floor auditorium), to be followed by a social/networking session at Top of the Hill (local brewery) at 5:30. My talk will open with my meandering career path, (hopefully) provide some guidance […]



Greenpeace a champion for genetic modification?

What does Greenpeace oppose more: Patents, or genetic modification? This question has been answered in a recent patent case where the European Patent Office (EPO) rejected a Monsanto patent for a technique for genetic modification of plants. The patent, which was due to expire in 2008, describes a method to use a ‘particle gun’ to […]



Indian biotechnology: Full of promise, challenged by patents

India’s biotechnology industry has the potential to become a major driver of the country’s economy, but is challenged by one vital omission: patent protection. While current patent laws support a strong Indian generic industry, they also impede foreign investment. Without foreign investment India loses trading opportunities, and without a capacity to produce branded drugs India […]



%d bloggers like this: